Dicerna Pharmaceuticals, Inc. (DRNA) financial statements (2022 and earlier)

Company profile

Business Address 75 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 568,843348,881302,626113,67845,87494,609
Cash and cash equivalents 126,023152,81654,23968,78920,86556,058
Short-term investments 442,820196,065248,38744,88925,00938,551
Restricted cash and investments 744     
Receivables 34,713200,354100,000   
Prepaid expense 8175835865573521,479
Other current assets  33068   
Other undisclosed current assets 13,5866,0212,2344,3231,60053
Total current assets: 618,703556,169405,514118,55847,82696,141
Noncurrent Assets
Finance lease, right-of-use asset 187 
Operating lease, right-of-use asset 60,84330,102
Property, plant and equipment  7,0762,7181,5122,2342,684
Restricted cash and investments 5,6183,8947447441,1161,116
Other noncurrent assets 5,13616865707682
Other undisclosed noncurrent assets 17,359     
Total noncurrent assets: 89,14341,2403,5272,3263,4263,882
TOTAL ASSETS: 707,846597,409409,041120,88451,252100,023
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 26,66515,77210,7028,7867,7318,997
Accounts payable 7,9016,0775,0134,9204,3182,621
Accrued liabilities 4,7332,3972,0051,8791,3004,284
Employee-related liabilities 14,0317,2983,6841,9872,1132,092
Deferred revenue 138,537212,258
Debt  3,358    
Estimated litigation liability   10,500   
Deferred revenue and credits6,000 4
Contract with customer, liability68,893
Other undisclosed current liabilities 12,73610,3473,9601,8602,313 
Total current liabilities: 177,938241,73594,05516,64610,0449,001
Noncurrent Liabilities
Long-term debt and lease obligation  20,141    
Operating lease, liability  20,141
Liabilities, other than long-term debt 343,410183,338114,2933,000  
Deferred revenue and credits3,000  
Deferred revenue 336,236182,730
Contract with customer, liability114,293
Other liabilities 1,174608    
Derivative instruments and hedges, liabilities 6,000     
Other undisclosed noncurrent liabilities 48,744     
Total noncurrent liabilities: 392,154203,479114,2933,000  
Total liabilities: 570,092445,214208,34819,64610,0449,001
Stockholders' equity
Stockholders' equity attributable to parent 137,754152,195200,693101,23841,20891,022
Common stock 877522
Additional paid in capital 775,809677,504605,495417,037296,962287,263
Accumulated deficit (638,063)(525,316)(404,809)(315,804)(255,756)(196,243)
Total stockholders' equity: 137,754152,195200,693101,23841,20891,022
TOTAL LIABILITIES AND EQUITY: 707,846597,409409,041120,88451,252100,023

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 164,30723,9046,1762,277295184
Revenue, net1,095  
Gross profit: 164,30723,9046,1762,277295184
Operating expenses (277,515)(152,090)(96,528)(62,864)(60,043)(63,211)
Operating loss: (113,208)(128,186)(90,352)(60,587)(59,748)(63,027)
Nonoperating income 4617,7271,499539235188
Investment income, nonoperating 6,0117,5372,102539235188
Other nonoperating income (expense) (5,530)193    
Interest and debt expense (20)(3)(603)   
Net loss: (112,767)(120,462)(89,456)(60,048)(59,513)(62,839)
Other undisclosed net income attributable to parent 203603   
Net loss attributable to parent: (112,747)(120,459)(88,853)(60,048)(59,513)(62,839)
Preferred stock dividends and other adjustments    (16,255)  
Other undisclosed net loss available to common stockholders, basic    (3,837)  
Net loss available to common stockholders, diluted: (112,747)(120,459)(88,853)(80,140)(59,513)(62,839)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (112,767)(120,462)(89,456)(60,048)(59,513)(62,839)
Comprehensive loss, net of tax, attributable to parent: (112,767)(120,462)(89,456)(60,048)(59,513)(62,839)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: